Interim trial results from a multi-center study show a 100% detection rate of sentinel lymph nodes with SENSEI® in prostate cancer surgery.
Lightpoint develops and markets surgical tools and technologies for real-time, intra-operative cancer detection.
With a strong pipeline of imaging, sensing and AI technologies, we are aiming to transform cancer surgery by enhancing surgical precision, improving patient outcomes, and reducing healthcare costs
There is an urgent medical need to provide real-time, intra-operative cancer detection. Over recent decades, robots have transformed cancer surgery. However, despite this technological progress, surgeons still remain completely dependent on their sight to detect cancer intra-operatively.
As a result, cancer is often left behind or healthy tissue is removed. Residual disease increases the need for further drug treatment, radiotherapy, and surgery. Similarly, removing healthy, functional tissue increases post-surgical complications and escalates healthcare costs.
By using next-generation sensor technologies and cancer-targeted imaging agents, already validated for whole-body imaging, such as SPECT/PET scans, we can provide real-time cancer detection optimized for minimally-invasive and robot-assisted surgery across a range of major cancer types.